Literature DB >> 25926685

Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells.

Alicia R Feagins1, Christopher F Basler1.   

Abstract

Marburg viruses (MARVs) cause highly lethal infections in humans and nonhuman primates. Mice are not generally susceptible to MARV infection; however, if the strain is first adapted to mice through serial passaging, it becomes able to cause disease in this animal. A previous study correlated changes accrued during mouse adaptation in the VP40 gene of a MARV strain known as Ravn virus (RAVV) with an increased capacity to inhibit interferon (IFN) signaling in mouse cell lines. The MARV strain Ci67, which belongs to a different phylogenetic clade than RAVV, has also been adapted to mice and in the process the Ci67 VP40 acquired a different collection of genetic changes than did RAVV VP40. Here, we demonstrate that the mouse-adapted Ci67 VP40 more potently antagonizes IFN-α/β-induced STAT1 and STAT2 tyrosine phosphorylation, gene expression, and antiviral activity in both mouse and human cell lines, compared with the parental Ci67 VP40. Ci67 VP40 is also demonstrated to target the activation of kinase Jak1. A single change at VP40 residue 79 was found to be sufficient for the increased VP40 IFN antagonism. These data argue that VP40 IFN-antagonist activity plays a key role in MARV pathogenesis in mice.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ci67 strain; Marburg virus; Ravn virus; VP40; interferon; mouse-adapted

Mesh:

Substances:

Year:  2015        PMID: 25926685      PMCID: PMC4564529          DOI: 10.1093/infdis/jiv010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Authors:  Loreen L Lofts; Jay B Wells; Sina Bavari; Kelly L Warfield
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.

Authors:  Mathieu Mateo; St Patrick Reid; Lawrence W Leung; Christopher F Basler; Viktor E Volchkov
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

4.  The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway.

Authors:  Megan R Edwards; Britney Johnson; Chad E Mire; Wei Xu; Reed S Shabman; Lauren N Speller; Daisy W Leung; Thomas W Geisbert; Gaya K Amarasinghe; Christopher F Basler
Journal:  Cell Rep       Date:  2014-03-13       Impact factor: 9.423

5.  The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation.

Authors:  Alicia R Feagins; Christopher F Basler
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

6.  Molecular characterization of guinea pig-adapted variants of Ebola virus.

Authors:  V E Volchkov; A A Chepurnov; V A Volchkova; V A Ternovoj; H D Klenk
Journal:  Virology       Date:  2000-11-10       Impact factor: 3.616

7.  Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.

Authors:  Charalampos Valmas; Christopher F Basler
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

8.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

Review 9.  Pathogenesis of the viral hemorrhagic fevers.

Authors:  Slobodan Paessler; David H Walker
Journal:  Annu Rev Pathol       Date:  2012-11-01       Impact factor: 23.472

Review 10.  The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.

Authors:  Osvaldo Martinez; Lawrence W Leung; Christopher F Basler
Journal:  Antiviral Res       Date:  2012-02-08       Impact factor: 5.970

View more
  12 in total

Review 1.  Innate immune evasion by filoviruses.

Authors:  Christopher F Basler
Journal:  Virology       Date:  2015-04-03       Impact factor: 3.616

Review 2.  Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.

Authors:  Ilhem Messaoudi; Gaya K Amarasinghe; Christopher F Basler
Journal:  Nat Rev Microbiol       Date:  2015-10-06       Impact factor: 60.633

3.  Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.

Authors:  Benjamin C Yen; Christopher F Basler
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

4.  Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.

Authors:  Caroline G Williams; Joyce Sweeney Gibbons; Timothy R Keiffer; Priya Luthra; Megan R Edwards; Christopher F Basler
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.

Authors:  Priya Luthra; Jacinth Naidoo; Colette A Pietzsch; Sampriti De; Sudip Khadka; Manu Anantpadma; Caroline G Williams; Megan R Edwards; Robert A Davey; Alexander Bukreyev; Joseph M Ready; Christopher F Basler
Journal:  Antiviral Res       Date:  2018-08-23       Impact factor: 5.970

Review 6.  Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Authors:  Logan Banadyga; Michael A Dolan; Hideki Ebihara
Journal:  J Mol Biol       Date:  2016-05-14       Impact factor: 5.469

7.  High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein.

Authors:  Priya Luthra; Manu Anantpadma; Sampriti De; Julien Sourimant; Robert A Davey; Richard K Plemper; Christopher F Basler
Journal:  ACS Infect Dis       Date:  2020-09-16       Impact factor: 5.084

8.  A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner.

Authors:  Alexander Koehler; Larissa Kolesnikova; Ulla Welzel; Gordian Schudt; Astrid Herwig; Stephan Becker
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

9.  Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time.

Authors:  Haiyan Wei; Jonathan Audet; Gary Wong; Shihua He; Xueyong Huang; Todd Cutts; Steven Theriault; Bianli Xu; Gary Kobinger; Xiangguo Qiu
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

Review 10.  Marburg Virus Reverse Genetics Systems.

Authors:  Kristina Maria Schmidt; Elke Mühlberger
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.